Zeo Scientifix Inc Quick Ratio (BPSR) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Zeo Scientifix Inc   (BPSR)

Zeo Scientifix Inc 's Quick Ratio

BPSR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Zeo Scientifix Inc 's Cash & cash equivalent grew by 735.29 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Zeo Scientifix Inc 's Quick Ratio to 0.59, above Zeo Scientifix Inc average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 121 other companies have achieved higher Quick Ratio than Zeo Scientifix Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2155 to 2269.

Explain Quick Ratio?
How much Cash & cash equivalents BPSR´s has?
What are BPSR´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BPSR Quick Ratio (Apr 30 2026)
Q2		 (Jan 31 2026)
Q1		 (Oct 31 2025)
Q4		 (Jul 31 2025)
Q3		 (Apr 30 2025)
Q2
Y / Y Current Liabilities Change -9.9 % -14.21 % -12.62 % 6.63 % -4.64 %
Y / Y Cash & cash equivalent Change 240.59 % -69.31 % -66.36 % -71.58 % -27.35 %
Quick Ratio MRQ 0.59 0.08 0.08 0.08 0.16
BPSR's Total Ranking # 2269 # 2155 # 3455 # 3208 # 3059
Seq. Current Liabilities Change 8.28 % 0 % -25.86 % 12.22 % 3.11 %
Seq. Cash & cash equivalent Change 735.29 % 0 % -29.62 % -42.07 % -24.72 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 122
Healthcare Sector # 711
Overall Market # 2269


Quick Ratio Statistics
High Average Low
1.88 0.26 0
(Jul 31 2013)   (Oct 31 2014)




Financial Statements
Zeo Scientifix Inc 's Current Liabilities $ 3 Millions Visit BPSR's Balance sheet
Zeo Scientifix Inc 's Cash & cash equivalent $ 2 Millions Visit BPSR's Balance sheet
Source of BPSR's Sales Visit BPSR's Sales by Geography


Cumulative Zeo Scientifix Inc 's Quick Ratio

BPSR's Quick Ratio for the trailling 12 Months

BPSR Quick Ratio

 (Apr 30 2026)
12 Months		 (Jan 31 2026)
12 Months		 (Oct 31 2025)
12 Months		 (Jul 31 2025)
12 Months		 (Apr 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -7.23 % -5.89 % -6.89 % -8.58 % -8.24 %
Y / Y Cash & cash equivalent TTM Growth -13.96 % -59.79 % -57.93 % -58.48 % -38.72 %
Quick Ratio TTM 0.2 0.1 0.13 0.16 0.22
Total Ranking TTM # 4091 # 2548 # 3332 # 3128 # 3301
Seq. Current Liabilities TTM Growth -2.62 % -3.51 % -2.97 % 1.76 % -1.21 %
Seq. Cash & cash equivalent TTM Growth 100.46 % -27.77 % -19.53 % -26.16 % -6.32 %

Quick ratio ranking by company, industry and sector >> Back to BPSR Financial Strength Comparisons >> Go to Compare BPSR Quick Ratio to its Competitors

On the trailing twelve months basis BPSR Cash & cash equivalent more than doubled by 240.59 % in Q2 2026 year on year, while Current Liabilities rose to $3 millions, this led to increase in in Zeo Scientifix Inc 's Quick Ratio to 0.2, above BPSR average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 142 other companies have achieved higher Quick Ratio than Zeo Scientifix Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2025 from 2548 to 4091.

Explain Quick Ratio?
How much Cash & cash equivalents BPSR´s has?
What are BPSR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 143
Healthcare Sector # 906
Within the Market # 4091


trailing twelve months Quick Ratio Statistics
High Average Low
0.5 0.15 0.02
(Jul 31 2023)   (Apr 30 2018)




Companies with similar Quick Ratio in the quarter ending Apr 30 2026, within Biotechnology & Pharmaceuticals Industry Quick RatioApr 30 2026 MRQ Cash & cash equivalentApr 30 2026 MRQ Current Liabilities
Neurocrine Biosciences Inc   1.58 $ 1,316.200  Millions$ 831.700  Millions
Jasper Therapeutics Inc   1.57 $ 14.144  Millions$ 8.996  Millions
Elutia Inc   1.56 $ 28.488  Millions$ 18.225  Millions
Ocugen Inc   1.54 $ 31.855  Millions$ 20.708  Millions
Protalix Biotherapeutics inc   1.52 $ 41.712  Millions$ 27.388  Millions
Eloxx Pharmaceuticals Inc   1.49 $ 6.363  Millions$ 4.264  Millions
Atara Biotherapeutics Inc   1.48 $ 8.360  Millions$ 5.645  Millions
Twist Bioscience Corporation  1.43 $ 171.671  Millions$ 119.976  Millions
Bio techne Corp  1.37 $ 209.819  Millions$ 153.278  Millions
Pelthos Therapeutics Inc   1.28 $ 31.976  Millions$ 25.003  Millions
Coherus Oncology inc   1.26 $ 167.048  Millions$ 132.332  Millions
Biocryst Pharmaceuticals Inc   1.22 $ 239.254  Millions$ 195.391  Millions
Sana Biotechnology Inc   1.17 $ 101.136  Millions$ 86.265  Millions
Curis Inc   1.09 $ 15.001  Millions$ 13.745  Millions
Armata Pharmaceuticals Inc   1.03 $ 4.754  Millions$ 4.635  Millions
Aim Immunotech Inc   1.00 $ 5.879  Millions$ 5.890  Millions
Lenz Therapeutics Inc   0.96 $ 24.772  Millions$ 25.806  Millions
Exozymes Inc   0.91 $ 1.445  Millions$ 1.582  Millions
Liminatus Pharma Inc   0.88 $ 1.908  Millions$ 2.167  Millions
Halozyme Therapeutics Inc   0.85 $ 309.749  Millions$ 363.210  Millions
Dbv Technologies S a   0.75 $ 42.600  Millions$ 56.796  Millions
Xtant Medical Holdings Inc   0.65 $ 12.137  Millions$ 18.773  Millions
Senti Biosciences Holdings Inc   0.63 $ 8.935  Millions$ 14.268  Millions
Silexion Therapeutics Corp  0.60 $ 2.440  Millions$ 4.060  Millions
Atlantic Coastal Acquisition Corp Ii  0.60 $ 5.453  Millions$ 9.117  Millions
Zeo Scientifix Inc   0.59 $ 1.846  Millions$ 3.111  Millions
Sangamo Therapeutics Inc   0.52 $ 27.586  Millions$ 53.134  Millions
Amgen Inc   0.48 $ 12,038.000  Millions$ 24,955.000  Millions
Biomx Inc  0.48 $ 1.168  Millions$ 2.447  Millions
Surrozen Inc   0.44 $ 106.910  Millions$ 243.155  Millions

Date modified: 2026-09-26T07:28:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.